Tinodasertib is a selective small-molecule inhibitor of the mitogen-activated protein kinase-interacting serine/threonine-protein kinases MNK1 and MNK2. By blocking the phosphorylation of eukaryotic initiation… Read more
Tinodasertib is a selective small-molecule inhibitor of the mitogen-activated protein kinase-interacting serine/threonine-protein kinases MNK1 and MNK2. By blocking the phosphorylation of eukaryotic initiation factor 4E, this compound is primarily utilized in research to study pathways involved in oncogenic transformation and tumor progression, particularly within clinical investigations for solid tumors and various leukemias. To support rigorous analytical testing and quality control for this drug, our category includes high-quality reference standards for Tinodasertib, its associated impurities, and metabolites. Pharmaceutical laboratories rely on these characterized reference standards, including stable isotope-labelled compounds, to perform accurate impurity profiling and quantitative analysis. These materials are essential for method validation and stability studies, ensuring that analytical methods effectively detect and quantify impurities throughout the drug development and manufacturing processes.